Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease, damage to eyes, kidneys and nerves, and premature death. Globally, more than 400 million adults live with diabetes, and diabetes directly caused 1....
Farrell, B;
Black, C;
Thompson, W;
McCarthy, L;
Rojas-Fernandez, C;
Lochnan, H;
Shamji, S;
Upshur, R;
Bouchard, M;
Welch, V.
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus, Type 2/drug therapy,
Hypoglycemic Agents/administration & dosage,
Glycemic Index,
Clinical Decision-Making,
Patient-Centered Care,
Biomarkers/blood,
Diabetes Mellitus, Type 2/blood,
Life Expectancy,
Fructosamine/blood,
Glycated Hemoglobin/analysis
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
Diabetes Mellitus, Type 2/drug therapy,
Arterial Pressure/drug effects,
Diabetic Angiopathies/prevention & control,
Glycated Hemoglobin,
Heart Rate/drug effects,
Hypoglycemic Agents/administration & dosage,
Metformin/administration & dosage,
Sulfonylurea Receptors/administration & dosage,
Weight Loss,
Drug Therapy, Combination
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus, Type 2,
Diabetes Mellitus,
Biomarkers/blood,
Blood Glucose/metabolism,
Diabetic Angiopathies/prevention & control,
Fructosamine/blood,
Glycated Hemoglobin/metabolism,
Hypoglycemic Agents/therapeutic use,
Life Expectancy,
Patient Preference,
Patient-Centered Care,
Glycated Hemoglobin,
Hypoglycemic Agents
Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones clínicas respecto del tratamiento farmacológico en pacientes adultos con diagnóstico de Diabetes Mellitus tipo
2, basadas en la mejor evidencia científica disponible y el consenso de expertos....
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Blood Glucose,
Combined Modality Therapy,
Diabetes Mellitus, Type 1,
Diabetes Mellitus, Type 2,
Diet, Diabetic,
Drug Monitoring,
Endocrinology,
Hyperglycemia,
Hypoglycemia,
Insulin/therapeutic use,
Insulin Infusion Systems,
Monitoring, Ambulatory,
Patient Education as Topic,
Precision Medicine,
Diabetes Mellitus, Type 1/drug therapy,
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 1/therapy,
Diabetes Mellitus, Type 2/therapy,
Hypoglycemic Agents/therapeutic use,
Hypoglycemic Agents/adverse effects,
Insulin/adverse effects
Determinar la utilidad, en nuestro medio, de estrategias de tamización como herramienta
para la detección y diagnóstico temprano de la diabetes mellitus tipo 2. Indicar las intervenciones farmacológicas y dentro de un plan de manejo multifactorial, escalonado de menor a mayor complejidad, haciendo é...
